ELANE p.Val101Met
c.301G>A · rs137854449 · VCV844491
Computational evidence
| Protein change | ||
| AlphaMissense | 0.651 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.596 | indeterminate |
| SaProt | LLR -13.86 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.2 | GERP -4.5 |
| Regional constraint | o/e 1.04 | unconstrained · MANE · 3,171 bp · p 0.52 · regional, not allelic |
| Overall | ||
| CADD | 13.16 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
No allele count reported in gnomAD v4.1 (AN 1,611,138). This is missing data, not an absence: the variant may or may not be present in gnomAD. Rarity (ACMG PM2) and BA1/BS1 cannot be assessed for it.
Variant & gene context
- Gene
- ELANE
- Protein
- p.Val101Met
- Coding
- c.301G>A
- MANE Select
- NM_001972
- dbSNP
- rs137854449
- Type
- single nucleotide variant
- Location
- chr19:853338 (GRCh38)
- Gene constraint
- LOEUF 1.245 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 88.42 · 38 PDB
- Residue 101
- a β-strand; the peptidase s1 domain; a UniProt-annotated variant site (in scn1; located on the same allele as l-98; reduces proteolytic enzyme activity by slightly less than half; together with l-98 shows an additive effect with minimal remaining enzyme activity); a UniProt-annotated variant site (in scn1)
Disease context
cyclic neutropenia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: neutropenia, severe congenital, 1, autosomal dominant
For Cyclic neutropenia (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- All ages
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- ELANE p.Val101Gly Pathogenic same residue
- ELANE p.Val101fs Uncertain significance ★★ same residue
- ELANE p.Val101= Benign/Likely benign ★★ same residue
- ELANE c.597+1G>A Pathogenic ★★ same condition
- ELANE c.597+1G>C Pathogenic ★★ same condition
- ELANE c.597+1G>T Pathogenic ★★ same condition
- ELANE c.597+5G>A Pathogenic/Likely pathogenic ★★ same condition
- ELANE p.Ala57Thr Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/elane-p-val101met (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown